Zhou, Jing published the artcileGadolinium complex and phosphorescent probe-modified NaDyF4 nanorods for T1– and T2-weighted MRI/CT/phosphorescence multimodality imaging, Recommanded Product: 1,2-Diphenyl-1H-benzo[d]imidazole, the publication is Biomaterials (2014), 35(1), 368-377, database is CAplus and MEDLINE.
To compensate for the deficiencies of individual imaging modalities, lanthanide-based nanoparticles are ideal building blocks for multifunctional contrast agents. Herein, oleic acid-coated NaDyF4 nanorods (DyNPs) were synthesized by the hydrothermal method, and then coated with α-cyclodextrin (α-CD) and modified with gadolinium complex (Gd-DTPA) to obtain hydrophilic and functionalized nanoparticles (DyNPs-Gd). By loading the phosphorescent probe (iridium-complex) within the surface hydrophobic layer, the developed nanophosphors (DyNPs-Gd-Ir) could be further applied in phosphorescent cell labeling. The Dy in the host induces a high X-ray absorption ability for X-ray computed tomog. (CT) and neg. enhancement for T2-weighted magnetic resonance imaging (MRI), whereas pos. contrast for T1-weighted MRI results from the Gd-DTPA. DyNPs-Gd-Ir has been successfully applied to T1– and T2-weighted MRI/CT in vivo. Toxicity studies demonstrated that DyNPs-Gd-Ir exhibited low toxicity to living systems. Therefore, DyNPs-Gd-Ir could be a platform for next-generation contrast agents for T1– and T2-weighted MRI/CT/phosphorescence multimodal imaging.
Biomaterials published new progress about 2622-67-5. 2622-67-5 belongs to imidazoles-derivatives, auxiliary class Benzimidazole,Benzene,Benzimidazole, name is 1,2-Diphenyl-1H-benzo[d]imidazole, and the molecular formula is CBF6K, Recommanded Product: 1,2-Diphenyl-1H-benzo[d]imidazole.
Referemce:
https://en.wikipedia.org/wiki/Imidazole,
Imidazole | C3H4N2 – PubChem